American Association for Cancer Research

AACR CANCER POLICY MONITOR

CPM

                                                                                                           APRIL 2009

AACR TO HOLD THREE CANCER POLICY FORUMS DURING ANNUAL MEETING

Policy forums will consider timely policy issues that affect cancer researchers

The AACR 100th Annual Meeting 2009, with the theme of "Science, Synergy and Success," will be held April 18-22 in Denver, Colorado. This year's meeting will feature three policy forums where attendees will have the opportunity to learn what the latest federal, state and local policies will mean for cancer research. Read more

SENATORS REVITALIZE THE NATION'S WAR ON CANCER

Senators Kennedy and Hutchison introduce long-anticipated cancer legislation

In late March, Senators Edward M. Kennedy (D-Mass.) and Kay Bailey Hutchison (R-Texas) introduced the long-anticipated 21st Century Cancer Access to Lifesaving Early Detection, Research and Treatment (ALERT) Act (S. 717), legislation that is intended to revitalize the war on cancer by modernizing and advancing the National Cancer Program of the United States. Read more

CONGRESS SETS BUDGET PRIORITIES FOR FY2010

House and Senate approve spending blueprints that indicate support for cancer research

With work on fiscal year (FY) 2009 appropriations and the economic stimulus package behind them, lawmakers are now focused on setting spending priorities for FY2010, which begins October 1. Read more

HOUSE VOTES TO ALLOW FDA TO REGULATE TOBACCO

Widely supported measure now advances to the Senate

The U.S. House of Representatives voted on April 2 to grant the U.S. Food and Drug Administration (FDA) authority to regulate the production and marketing of tobacco products. Read more

SEBELIUS CONFIRMATION STALLED

Vote to confirm HHS nominee delayed until after April 20

The U.S. Senate adjourned on April 2 for a two-week recess without holding an expected vote to confirm Secretary of Health and Human Services (HHS) nominee, Governor Kathleen Sebelius. Read more

HAMBURG SELECTED TO LEAD FDA

Appointee still awaiting senate confirmation

Margaret Hamburg, M.D., has been nominated to become the next commissioner of the Food and Drug Administration (FDA). Read more

DEBATE HEATS UP OVER COMPARATIVE EFFECTIVENESS RESEARCH

Stakeholders weigh in on research design and use of data

As a result of the recent economic stimulus act, there will soon be a surge of comparative effectiveness research (CER) aimed at better understanding and comparing the clinical merits of different treatments, devices and procedures. Read more

LEGISLATORS PROPOSE REGULATORY PATHWAYS FOR GENERIC BIOTECH DRUGS

Potential for health care savings drives increased interest in generic biologics

Two competing proposals have recently been introduced to help establish a regulatory pathway for the approval of generic biologics. Read more

Top